Dilution profile // every instrument, one screen, from SEC filings

ELITE PHARMACEUTICALS INC /NV/ (ELTP)

CIK 1053369 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3 on file 2020-07-15
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW+6% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-08-102026-06-27

Latest: 1.08B shares as of Jun 27, 2026 (10-K).

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

TrancheWarrantsExercise priceTermNotes
Series J Warrantsnot tagged$0.1521

Tranches exactly as the company dimensioned them in its 10-K filed Jun 29, 2026. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-K filed Jun 29, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

EXECUTEDAug 27, 2020Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEJul 27, 2020Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEJul 27, 2020SEC declared a registration effective — selling can beginEFFECT
REGISTEREDJul 15, 2020S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDJul 9, 2020Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEJun 5, 2017Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEJun 5, 2017SEC declared a registration effective — selling can beginEFFECT
REGISTEREDJun 2, 2017S-3/A registration — capacity to sell shares, not a sale yetS-3/A
REGISTEREDMay 10, 2017S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMay 2, 2017Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDApr 28, 2017Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEFeb 9, 2017Prospectus update — often a resale registration, not necessarily new capital424B3

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full ELTP workspace